{"nct_id":"NCT04000529","title":"Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies","status":"TERMINATED","status_verified_date":"2025-09","start_date":"2019-07-30","start_date_type":"ACTUAL","primary_completion_date":"2024-01-15","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-15","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}